Scott Lassman News Today

Legal experts say the ruling opens the door for legal challenges to practically any US medication.

Legal experts fear the ruling could also stifle development of future drugs.

Legal experts say the ruling opens the door for legal challenges to practically any US medication.

The U.S. FDA approved mifepristone, part of a two-drug regimen that accounts for more than half of U.S. abortions, over 20 years ago.

By Ahmed Aboulenein WASHINGTON (Reuters) - A federal judge's decision last week to suspend the U.S. Food and Drug Administration's (FDA) approval of a...

WASHINGTON (Reuters) - A federal judge's decision last week to suspend the U.S. Food and Drug Administration's (FDA) approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said. | 06:02am

A federal judge's decision last week to suspend the U.S. Food and Drug Administration's (FDA) approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said.

A federal judges decision to suspend FDA approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts have said.

The U.S. FDA approved mifepristone, part of a two-drug regimen that accounts for more than half of U.S. abortions, over 20 years ago.

The conflicting opinions probably mean a fast track for a legal showdown before a conservative Supreme Court that overturned the constitutional right to an abortion last June.